← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 255 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing255+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services79−3.2 pts t -0.5−1.9 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515669425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

OIMAU
OneIM Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OIMAW
OneIM Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OKUR
OnKure Therapeutics, Inc.
Below Treasuries
Healthcare Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OKYO
OKYO Pharma Ltd
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OLB
OLB GROUP, INC.
Below Treasuries
Technology Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +50.0% · below model
OLMA
Olema Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OLOX
OLENOX INDUSTRIES INC.
Below Treasuries
Industrials Risk 74 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +19.9%/yr vs model +0.0% · above model
OM
Outset Medical, Inc.
Below Treasuries
Healthcare Risk 48 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OMAB
Central North Airport Group
Below Treasuries
Industrials
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OMER
OMEROS CORP
Below Treasuries
Healthcare Risk 59 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OMEX
ODYSSEY MARINE EXPLORATION INC
Below Treasuries
Industrials Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +80.0%/yr vs model +2.0% · above model
OMSE
OMS Energy Technologies Inc.
Below Treasuries
Industrials Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ON
ON SEMICONDUCTOR CORP
Below Treasuries
Technology Risk 38 · Moderate
Yield3.3%
Growth used4.9%
10-yr IRR1.7%
Steady compounder · 5 yrs positive P/IV —
Market implies +23.0%/yr vs model +4.9% · above model
ONCH
1RT Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ONCHU
1RT Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ONCHW
1RT Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ONCY
ONCOLYTICS BIOTECH INC
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ONDS
Ondas Inc.
Below Treasuries
Technology Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +50.0% · below model
ONIT
ONITY GROUP INC.
Below Treasuries
Financial Services Risk 58 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +23.2%/yr vs model +7.9% · above model
ONMD
OneMedNet Corp
Below Treasuries
Industrials Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +63.7%/yr vs model +15.0% · above model
ONMDW
OneMedNet Corp
Below Treasuries
Industrials Risk 59 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +15.0%/yr vs model +2.0% · above model
ONON
On Holding AG
Below Treasuries
Consumer Cyclical Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ONTO
ONTO INNOVATION INC.
Below Treasuries
Healthcare Risk 40 · Elevated
Yield1.6%
Growth used3.0%
10-yr IRR-7.6%
Steady compounder · 4 yrs positive P/IV —
Market implies +30.8%/yr vs model +3.0% · above model
OPFI
OppFi Inc.
Below Treasuries
Financial Services Risk 38 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +13.2% · below model
OPP
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OPRA
Opera Ltd
Below Treasuries
Technology Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OPTH
Optimi Health Corp.
Below Treasuries
Healthcare
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OPTX
SYNTEC OPTICS HOLDINGS, INC.
Below Treasuries
Healthcare Risk 53 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +47.4%/yr vs model +2.0% · above model
OPTXW
SYNTEC OPTICS HOLDINGS, INC.
Below Treasuries
Healthcare Risk 67 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OR
OR Royalties Inc.
Below Treasuries
Basic Materials Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORA
ORMAT TECHNOLOGIES, INC.
Below Treasuries
Utilities Risk 64 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORGN
Origin Materials, Inc.
Below Treasuries
Basic Materials Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +35.9%/yr vs model +0.0% · above model
ORIC
Oric Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORIO
Orion Digital Corp.
Below Treasuries
Financial Services Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORIQ
Origin Investment Corp I
Below Treasuries
Financial Services Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORIQU
Origin Investment Corp I
Below Treasuries
Financial Services Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORIQW
Origin Investment Corp I
Below Treasuries
Financial Services Risk 61 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORKA
Oruka Therapeutics, Inc.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORLA
Orla Mining Ltd.
Below Treasuries
Basic Materials Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ORMP
ORAMED PHARMACEUTICALS INC.
Below Treasuries
Healthcare Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +85.4%/yr vs model +2.0% · above model
OSCR
Oscar Health, Inc.
Below Treasuries
Financial Services Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OSRH
OSR Holdings, Inc.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +10.9%/yr vs model +15.0% · below model
OSS
ONE STOP SYSTEMS, INC.
Below Treasuries
Technology Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +58.3%/yr vs model +2.0% · above model
OSTX
OS Therapies Inc
Below Treasuries
Healthcare Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OSUR
ORASURE TECHNOLOGIES INC
Below Treasuries
Healthcare Risk 41 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +17.8%/yr vs model +2.0% · above model
OTF
Blue Owl Technology Finance Corp.
Below Treasuries
Unknown Risk 49 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OTGA
OTG Acquisition Corp. I
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OTGAU
OTG Acquisition Corp. I
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OTGAW
OTG Acquisition Corp. I
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OTLK
Outlook Therapeutics, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +42.2%/yr vs model +15.0% · above model
OTLY
Oatly Group AB
Below Treasuries
Consumer Defensive Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OUST
Ouster, Inc.
Below Treasuries
Industrials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +43.3%/yr vs model +49.9% · below model
OVID
Ovid Therapeutics Inc.
Below Treasuries
Healthcare Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +75.8%/yr vs model +2.0% · above model
OWLS
OBOOK HOLDINGS INC.
Below Treasuries
Technology
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OXLC
Oxford Lane Capital Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OXLCG
Oxford Lane Capital Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OXLCI
Oxford Lane Capital Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OXLCL
Oxford Lane Capital Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OXLCM
Oxford Lane Capital Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OXLCN
Oxford Lane Capital Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —